According to Precision BioSciences
's latest financial reports the company has $0.11 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.18 B | 31.96% |
2021-12-31 | $0.14 B | 59.98% |
2020-12-31 | $89.79 M | -50.36% |
2019-12-31 | $0.18 B | 75.29% |
2018-12-31 | $0.10 B | 64.31% |
2017-12-31 | $62.8 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | 78.43% | ๐บ๐ธ USA |